scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...986353W |
P356 | DOI | 10.1371/JOURNAL.PONE.0086353 |
P932 | PMC publication ID | 3904882 |
P698 | PubMed publication ID | 24489717 |
P5875 | ResearchGate publication ID | 260063182 |
P2093 | author name string | Bo Akerström | |
Stefan R Hansson | |||
David Ley | |||
Matthias Mörgelin | |||
Martin E Johansson | |||
Bengt Rippe | |||
Magnus Gram | |||
Karel Marsal | |||
Sigurbjörg Rutardottir | |||
Anneli Edström-Hägerwall | |||
Josefin Axelsson | |||
Vera Casslén | |||
Iréne Larsson | |||
Lena Wester-Rosenlöf | |||
Behnaz Shohani | |||
Madlene Holmqvist | |||
P2860 | cites work | Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties | Q24292393 |
The pregnant sheep as a model for human pregnancy | Q24657385 | ||
Up-regulation of A1M/α1-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage | Q28477940 | ||
Redox properties of the lipocalin alpha1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron | Q31145047 | ||
Up-regulation of alpha1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines | Q33275367 | ||
The pathogenetic role of heme in pregnancy-induced hypertension-like disease in ewes. | Q51571837 | ||
The lipocalin alpha1-microglobulin has radical scavenging activity. | Q52683063 | ||
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
Production of recombinant human alpha1-microglobulin and mutant forms involved in chromophore formation. | Q54450337 | ||
Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia | Q61848157 | ||
Immunological analysis of alpha 1-microglobulin in different mammalian and chicken serum. alpha 1-Microglobulin is 5-8 kilodaltons larger in primates | Q69382677 | ||
Is oxidative stress the link in the two-stage model of pre-eclampsia? | Q78258200 | ||
Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria and autoimmune hemolytic anemia | Q81342772 | ||
Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1-microglobulin | Q83487574 | ||
Collagen VI is a subepithelial adhesive target for human respiratory tract pathogens | Q84019923 | ||
Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats | Q84425205 | ||
Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes | Q33312878 | ||
Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays | Q33872123 | ||
Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. | Q34073697 | ||
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease | Q34158521 | ||
A current concept of eclampsia | Q35156657 | ||
The placenta in preeclampsia | Q36053252 | ||
Comparative placentation: some interesting modifications for histotrophic nutrition -- a review. | Q36365576 | ||
Hemoglobin and heme scavenging. | Q36411315 | ||
Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment | Q36927608 | ||
Endotoxin limits in formulations for preclinical research | Q36936944 | ||
The two stage model of preeclampsia: variations on the theme | Q37187589 | ||
Evolutionary aspects of hemoglobin scavengers. | Q37570502 | ||
Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives | Q37573785 | ||
Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulin | Q37983081 | ||
Bystander cell death and stress response is inhibited by the radical scavenger α(1)-microglobulin in irradiated cell cultures | Q39642906 | ||
The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species | Q39949399 | ||
Distribution of iodine 125-labeled alpha1-microglobulin in rats after intravenous injection. | Q42500896 | ||
Pregnancy-induced hypertension: development of a model in the pregnant sheep | Q43410452 | ||
Prevention of pre-eclampsia | Q43625987 | ||
Inhibitory effects of methylxanthines on the pre-eclamptic-like symptoms in ewes | Q43768781 | ||
Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. | Q44044678 | ||
In vivo rat model of preeclampsia | Q44271036 | ||
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability | Q45746271 | ||
Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions | Q46075954 | ||
Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia | Q46332725 | ||
Characterisation of monoclonal antibodies to ovine interleukin-6 and the development of a sensitive capture ELISA. | Q46538950 | ||
Rat alpha 1-microglobulin. Purification from urine and synthesis by hepatocyte monolayers | Q46903264 | ||
Alpha1-microglobulin is found both in blood and in most tissues | Q47813923 | ||
Endothelial dysfunction in preeclampsia | Q47879591 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | e86353 | |
P577 | publication date | 2014-01-28 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia | |
P478 | volume | 9 |
Q35586953 | A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit |
Q35044854 | A1M/α1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation |
Q64969769 | Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model. |
Q38771575 | An evaluation of the antioxidant protein α1-microglobulin as a renal tubular cytoprotectant |
Q91555826 | Aspirin in the prevention of preeclampsia: the conundrum of how, who and when |
Q35929712 | Biodistribution and pharmacokinetics of recombinant α1-microglobulin and its potential use in radioprotection of kidneys. |
Q36357099 | Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? |
Q34630415 | Characterization of heme binding to recombinant α1-microglobulin |
Q46311114 | Decitabine Improves the Clinical Manifestations of Rats With l-NAME-Induced Pre-eclampsia: A Potential Approach to Studying Pre-eclampsia |
Q26801681 | Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders |
Q59335271 | Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction |
Q26773377 | Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy |
Q38674096 | Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities |
Q58696953 | Knockdown of pleiotrophin increases the risk of preeclampsia following vitrified-thawed embryo transfer |
Q92006760 | Longitudinal changes in plasma hemopexin and alpha-1-microglobulin concentrations in women with and without clinical risk factors for pre-eclampsia |
Q26773521 | Oxidative Stress in Placenta: Health and Diseases |
Q26830141 | Oxidative stress in preeclampsia and the role of free fetal hemoglobin |
Q47330519 | Podocytes are new cellular targets of haemoglobin-mediated renal damage. |
Q91893537 | Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis |
Q35124440 | Preeclampsia - will orphan drug status facilitate innovative biological therapies? |
Q103001912 | Pregnant alpha-1-microglobulin (A1M) knockout mice exhibit features of kidney and placental damage, hemodynamic changes and intrauterine growth restriction |
Q33870546 | Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells |
Q37732172 | The 2015 Pregnancy Summit, London, UK |
Q35774227 | The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators |
Q40360102 | The Role of Mitochondria, Oxidative Stress, and the Radical-binding Protein A1M in Cultured Porcine Retina |
Q92591056 | The heme and radical scavenger α1-microglobulin (A1M) confers early protection of the immature brain following preterm intraventricular hemorrhage |
Q40488401 | Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia. |
Q52689520 | rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury. |
Search more.